8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2005 / Narrative review
This review summarizes current knowledge on the neurological complications and pathophysiology of classical galactosemia. While initiating dietary restriction of galactose in the newborn period reverses hepatic, renal, brain, and immune dysfunction and reduces accumulated metabolites, patients often experience substantial motor, cognitive, and psychiatric impairments despite dietary treatment. Chronic and progressive neurological complications can develop even in patients who were spared neonatal symptoms.
Ridel KR, Leslie ND, Gilbert DL Pediatr Neurol, 2005. PMID 16087312
2005 / Narrative review
This review examines the regulatory framework of the Dietary Supplement Health and Education Act of 1994 (DSHEA) and the history of ephedra, a supplement used for weight loss. Due to sympathomimetic activity, ephedra caused stroke, cardiac arrhythmia, and death, prompting an FDA ban on its sale effective April 12, 2004. An evaluation of other dietary supplements attempting to fill the void demonstrates a general lack of safety and efficacy data. Ten years after DSHEA, the industry remains controversial and a concern for consumer safety.
Seamon MJ, Clauson KA J Herb Pharmacother, 2005. PMID 16520299
2004 / Narrative review and case reports
This paper reviews the chemistry, sources, metabolism, toxicology, and mechanism of toxicity of domoic acid, as well as human case reports of amnesic shellfish poisoning (ASP). ASP occurs from consuming shellfish contaminated with domoic acid produced by certain phytoplankton, leading to neuronal degeneration and necrosis in parts of the hippocampus. A 1987 Canadian outbreak linked to contaminated mussels resulted in 150 reported cases, 19 hospitalizations, and 4 deaths, with symptoms spanning gastrointestinal issues to hallucinations, memory loss, and coma.
Jeffery B, Barlow T, Moizer K, et al. Food Chem Toxicol, 2004. PMID 15019178
2004 / Literature review
This review summarizes literature data on levels of norharman and harman in fried meat and fish, meat extracts, alcoholic beverages, coffee brews, edible and medicinal plants, and tobacco smoke. Dietary exposure is estimated up to 4 µg norharman/kg body weight/day and 1 µg harman/kg body weight/day, while endogenous formation is estimated at 50-100 ng/kg body weight/day for norharman and about 20 ng/kg body weight/day for harman. Biomarker studies show elevated plasma levels in certain diseased patients, alcoholics, and following smoking or consumption of beta-carboline-containing food.
Pfau W, Skog K J Chromatogr B Analyt Technol Biomed Life Sci, 2004. PMID 15036003
2004 / Review
This review examines mechanisms by which free fatty acids inhibit glucose utilization in human skeletal muscle. While rat studies showed glucose-6-phosphate accumulation from substrate competition, human muscle studies demonstrate that free fatty acids decrease glucose-6-phosphate, pointing to direct inhibition of glucose transport/phosphorylation. This mechanism may redirect glucose from muscle to the brain during fasting and explain insulin resistance linked to obesity and high-lipid diets.
Roden M News Physiol Sci, 2004. PMID 15143200
2004 / Narrative review
This review examines the epidemiology, causes, diagnosis, and management of vitamin B12 (cobalamin) deficiency in elderly individuals. Cobalamin deficiency occurs frequently (> 20%) in elderly people but is often unrecognized due to subtle manifestations that are potentially serious neuropsychiatrically and hematologically. The most frequent causes are food-cobalamin malabsorption syndrome (> 60% of all cases) and pernicious anemia (15%-20% of all cases), along with insufficient dietary intake and malabsorption.
Andrès E, Loukili NH, Noel E, et al. CMAJ, 2004. PMID 15289425
2004 / Narrative review
Epidemiological research demonstrates that smoking is associated with a reduced incidence of Parkinson's disease. Smoke contains multiple chemicals that may contribute to this observation, with nicotine specifically considered due to its stimulation of brain dopaminergic systems, neuroprotective effects, and provision of symptomatic benefit in the disease. Exploring nicotine's putative factors and signaling pathways is highlighted as crucial for developing intervention strategies to slow or stop Parkinson's disease progression.
Shows an association, not proof of cause and effect.
Quik M Trends Neurosci, 2004. PMID 15331239
2004 / Critical review of 57 experimental and 9 survey studies
Researchers conducted a critical review of 57 experimental and 9 survey studies to validate human caffeine withdrawal symptoms and syndrome characteristics. Ten symptom categories met validity criteria: headache, fatigue, decreased energy/activeness, decreased alertness, drowsiness, decreased contentedness, depressed mood, difficulty concentrating, irritability, and foggy/not clearheaded. In experimental studies, the incidence of headache was 50% and clinically significant distress or functional impairment was 13%. Onset typically occurred 12-24 hours after abstinence, peaked at 20-51 hours, and lasted 2-9 days, with symptoms observed from doses as low as 100 mg/day.
Juliano LM, Griffiths RR Psychopharmacology (Berl), 2004. PMID 15448977
2003 / Narrative review / proposed disease model
This review presents an autism model based on the discovery of food protein-derived opioid peptides (exorphins) in the urine of autistic patients. The authors suggest that exorphins and serotonin uptake-stimulating factors may explain many signs, symptoms, and behavioural effects seen in autistic disorders. They propose that these compounds are key mediators of autism development, potentially caused by genetically based peptidase deficiencies triggered by dietary overload of exorphin precursors or increased gut uptake.
Reichelt KL, Knivsberg AM Nutr Neurosci, 2003. PMID 12608733
2003 / Review
Arachidonic acid (ARA) and docosahexaenoic acid (DHA) are long-chain polyunsaturated fatty acids (LCPUFA) concentrated in brain and retinal membranes. Infants fed infant formula (IF) containing LCPUFA achieve red cell and plasma ARA and DHA levels comparable to breastfed infants, unlike those fed IF with only precursor fatty acids. However, functional benefits regarding visual or neural development from LCPUFA-supplemented formula remain controversial, and risks of excessive or imbalanced intake exist as other infant foods are fortified.
Koo WW J Am Coll Nutr, 2003. PMID 12672705
2003 / Narrative review
This review examines the health effects of rye, plant lignans, and the dietary fibre complex. Human evidence does not currently warrant the conclusion that rye, whole grains, or phyto-oestrogens protect against cancer, though some studies suggest benefits for upper digestive tract cancers. Conversely, prospective epidemiological studies demonstrate protective effects of wholegrain cereals against myocardial infarction, diabetes, and ischaemic stroke, likely tied to factors within the dietary fibre complex.
Shows an association, not proof of cause and effect.
Hallmans G, Zhang JX, Lundin E, et al. Proc Nutr Soc, 2003. PMID 12749346
2003 / Narrative review
This review summarizes findings on the possible relationship between beta-casomorphin (beta-CM) and apnea in sudden infant death syndrome (SIDS). Beta-CM is an exogenous bioactive peptide derived from casein in milk with opioid activity. The authors discuss how circulating beta-CM might cross the immature blood-brain barrier and inhibit the brainstem respiratory center, potentially leading to apnea.
Shows an association, not proof of cause and effect.
Sun Z, Zhang Z, Wang X, et al. Peptides, 2003. PMID 12948848
2003 / Narrative review
This review notes that aluminium toxicity, initially linked to bone and brain disorders in chronic renal failure, can occur via dialysis fluids, parenteral nutrition, and oral medications like antacids and phosphate binders. Over-the-counter antacids represent the most important quantitative source of human aluminium exposure, with potential neurotoxic as well as embryonic and fetal toxic effects. However, European patient information leaflets for over-the-counter antacids differ substantially in their warnings, including those regarding increased absorption from concomitant citrate-containing beverages and use during pregnancy.
Reinke CM, Breitkreutz J, Leuenberger H Drug Saf, 2003. PMID 14583063
2003 / Narrative review
This review summarizes the history and metabolic understanding of ketones. In the 1920s, a hyperketogenic diet proved effective for drug-resistant pediatric epilepsy, and in 1967 ketones were shown to replace glucose as the brain's major fuel during prolonged fasting. Diet-induced hyperketonemia was later found therapeutic for rare genetic disorders affecting neuronal glucose use. Given evidence of mitochondrial dysfunction and reduced bioenergetic efficiency in Parkinson's and Alzheimer's disease brains, the authors note that hyperketogenic diets should be evaluated for potential benefits in these conditions.
VanItallie TB, Nufert TH Nutr Rev, 2003. PMID 14604265
2003 / Review
Quinine is widely available in beverages including tonic water and bitter lemon, despite a U.S. FDA ban for nocturnal leg cramps due to lack of safety and efficacy. Numerous anecdotal reports suggest quinine-containing products may produce neurological complications, including confusion, altered mental status, seizures, and coma, particularly in older women. The abstract states that psychologists need to inquire about the consumption of quinine-containing beverages as part of an evaluation process.
Shows an association, not proof of cause and effect.
Brasić JR Psychol Rep, 2003. PMID 14765563
2002 / Narrative review
This review introduces literature examining the impact of chemical exposures on the developing brain. Research demonstrates that substances such as lead, mercury, and PCBs impair development at exposure levels currently experienced by significant portions of the general population, contributing to deficits in attention, memory, learning, social behavior, and IQ. Among the 3,000 chemicals produced in the highest volumes, only 12 have been adequately tested for neurodevelopmental effects.
Stein J, Schettler T, Wallinga D, et al. J Dev Behav Pediatr, 2002. PMID 11875286
2002 / Narrative review / hypothesis paper
The Chamorro people of Guam have experienced a complex of neurodegenerative diseases (ALS-PDC) with similarities to ALS, Alzheimer's disease, and Parkinson's disease at much higher rates than other populations. The authors propose that Chamorro consumption of flying foxes, which forage on neurotoxic cycad seeds, may have delivered high cumulative doses of plant neurotoxins resulting in ALS-PDC neuropathologies.
Shows an association, not proof of cause and effect.
Cox PA, Sacks OW Neurology, 2002. PMID 11914415
2002 / Narrative review
This review examines the roles of creatine and creatine kinase in health and disease. Oral creatine supplementation improved clinical symptoms in patients with AGAT and GAMT deficiencies, though not in creatine transporter deficiency. Additionally, it showed neuroprotective effects in animal models of Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis. The authors note creatine may also reduce plasma homocysteine production to potentially lower atherosclerotic risk, but these findings require confirmation and safety evaluations in human clinical studies.
Wyss M, Schulze A Neuroscience, 2002. PMID 12044443
2002 / Narrative review with author data
Vegetarians are at risk for vitamin B-12 deficiency due to low intake from animal-derived foods. Serum vitamin B-12 measurement has poor predictive value, and optimal monitoring should include homocysteine (HCY), methylmalonic acid (MMA), and holotranscobalamin II across four stages of deficiency. In their investigations, the authors found stage III vitamin B-12 deficiency (elevated HCY and MMA with lowered holotranscobalamin II) in over 60% of vegetarians.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Herrmann W, Geisel J Clin Chim Acta, 2002. PMID 12417096
2002 / Review
A review discusses integrative medical management for autism spectrum disorders (ASD). The authors state that dietary restrictions (removing casein, gluten, sugar, chocolate, preservatives, and food coloring) are beneficial and prerequisite to other interventions. They also report that supplements like dimethylglycine and pyridoxine with magnesium benefit roughly half of cases, alongside other nutrients, gastrointestinal interventions, and chelation. Additionally, the abstract asserts that current pharmaceuticals fail to benefit primary symptoms and can cause marked adverse effects.
Kidd PM Altern Med Rev, 2002. PMID 12495373
2002 / Review
This review details the physiological and clinical roles of the semi-essential amino acid arginine. As a precursor to nitric oxide, arginine can be used in therapeutic regimens for angina pectoris, congestive heart failure, hypertension, coronary heart disease, preeclampsia, intermittent claudication, and erectile dysfunction. Additionally, arginine has been studied for applications in HIV/AIDS, athletic performance, burns and trauma, cancer, diabetes, gastrointestinal diseases, infertility, interstitial cystitis, immunomodulation, and senile dementia. Considerations regarding toxicity, dosage, and contraindications are also reviewed.
Appleton J Altern Med Rev, 2002. PMID 12495375
2001 / Narrative review
This review evaluates the safety of dietary aluminum exposure. Aluminum in food comes from natural sources, water, food ingredients, and utensils, with less than 1% typically absorbed systemically and excreted mainly in urine and feces. No reports of dietary aluminum toxicity to healthy individuals exist, and high intake from antacids has not been correlated with neurotoxicity or Alzheimer's disease. Cooking with aluminum utensils results in statistically significant, but relatively small, increases in food aluminum content, and common aluminum-containing food ingredients approved by the FDA are indicated as safe.
Soni MG, White SM, Flamm WG, et al. Regul Toxicol Pharmacol, 2001. PMID 11259180
2001 / Technical report / narrative review
This technical report reviews environmental sources, toxicity, and the prevention and treatment of mercury exposure. Mercury exists in elemental, inorganic, and organic forms, with exposure occurring primarily via inhalation or ingestion. Because fresh-water and ocean fish can contain large amounts of mercury, pregnant women and children face significant exposure through excessive fish consumption. Developing fetuses and young children are disproportionately affected, with mercury potentially disturbing development, particularly brain maturation.
Goldman LR, Shannon MW, American Academy of Pediatrics: Committee on Environmental Health Pediatrics, 2001. PMID 11433078
2001 / Narrative review / hypothesis
Three case-control studies found diets high in animal fat or cholesterol were associated with a substantially increased risk for Parkinson's disease (PD), while plant fat did not appear to increase risk. Furthermore, populations consuming vegan or quasi-vegan diets, such as sub-Saharan black Africans, rural Chinese, and Japanese, appear to have substantially lower rates of PD compared to Europe and the Americas. Because African-Americans have PD prevalence similar to whites, environmental factors likely explain the lower risk in black Africans. The author hypothesizes that vegan diets may protect against PD or slow its progression, though available data do not clarify the specific mediating components.
Shows an association, not proof of cause and effect.
McCarty MF Med Hypotheses, 2001. PMID 11516224